Ukraine registers single-dose COVID-19 vaccine Janssen manufactured by Johnson&Johnson
Ukraine has registered a vaccine against coronavirus (COVID-19) Janssen manufactured by Johnson & Johnson.
According to the Center for Public Health and the Health Ministry, the vaccine was registered for emergency medical use on July 2.
At the same time, it is specified that one dose of Janssen vaccine is sufficient for complete immunization.
The vaccine is approved for emergency use by WHO. The United States, Great Britain, the European Union, Switzerland, Canada and other countries have also given permission to use it.
This is a vector vaccine developed by Janssen, owned by Johnson&Johnson. It requires a storage temperature from minus two to plus eight degrees Celsius.
Advertising
Advertising
MORE ABOUT
Sanofi plans to supply 50,000 doses of flu vaccine to private market in Ukraine this epidemic season
09:32, 30.09.2022
UNICEF provides Ukraine with 100,000 doses of Covid-19 Vaccine Janssen (Jcovden) under COVAX initiative
15:38, 25.08.2022
Health Ministry to begin delivering single-dose COVID-19 vaccine by Johnson & Johnson around Ukraine
13:48, 10.08.2022
Liashko: almost 31 mln doses of COVID-19 vaccine imported to Ukraine, another 2.5 mln doses of Pfizer vaccine expected this week
10:49, 09.11.2021
Ukraine does not consider supplies of Johnson & Johnson vaccine - Kuzin
16:40, 25.10.2021
LATEST
Poroshenko transfers two more Ai-Petri systems to the military
16:34, 10.03.2025
Trump considers halting US weapons supplies to Ukraine until Zelenskyy leaves office – media
16:27, 10.03.2025
Ukraine and Türkiye agree to expand cooperation, in particular interaction between cities and regions – President’s Office
16:24, 10.03.2025
Ninety-five people evacuated from Donetsk region to safer regions of Ukraine since early March – regional administration
15:47, 10.03.2025
Trump announces 'almost' end of pause in intelligence sharing with Ukraine